Learn about the global nucleic acid-based gene therapy market through The Business Research Company, which provides information on nucleic acid-based gene therapy market size, nucleic acid-based gene therapy market drivers and restraints, nucleic acid-based gene therapy market players, the COVID-19 impact on the nucleic acid-based gene therapy market, and more.

The global nucleic acid-based gene therapy market grew from $1,391.9 million in 2015 to $4,726.8 million in 2020 at a compound annual growth rate (CAGR) of 27.7%. The nucleic acid-based gene therapy market is expected to grow from $4,726.8 million in 2020 to $7,282.9 million in 2025 at a rate of 9.0%. The nucleic acid-based gene therapy market is then expected to grow at a CAGR of 15.4% from 2025 and reach $14,909.6 million in 2030.

The rise in healthcare spending is to increase the market for nucleic acid-based gene therapy in the near future.

Request A Sample For The Global Nucleic Acid Based Gene Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5574&type=smp

The nucleic acid-based gene therapy market consists of sales of nucleic acid-based gene therapy products and services. Gene therapy is used for correcting defective genes that are responsible for disease development. Nucleic acid therapies are highly specific and long-lasting compared to the conventional therapies which are generally transient and have low specificity. Nucleic acid-based therapy either uses unmodified DNA or RNA or closely related compounds. Nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there is no permanent cure such as anemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.

Global Nucleic Acid-Based Gene Therapy Market Segments Include:

By Nucleic Acid Technology: Anti-Sense and Anti-Gene Oligonucleotides, siRNA and RNA Interference, Gene Transfer Therapy, Ribozymes, Aptamers, Others

By Application: Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases, Others

By End User: Hospitals And Clinics, Academic And Research Institutes

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the global nucleic acid-based gene therapy market, accounting for 46.2% of the total in 2020.

Major players operating in the nucleic acid-based gene therapy market are continuously collaborating or partnering with technology companies to integrate advanced technologies for the improvement of gene therapy. Advanced technologies such as artificial intelligence (AI) and big data are used for personalizing and manufacturing improved gene therapy. Machine Learning enables accelerated analysis of the sequenced data and enables effective prediction of the genetic alterations associated with a disease. This helps in reducing the time and effort required in the process of developing precision medicine.

TBRC’s nucleic acid-based gene therapy market report covers:

Major Market Players: Copernicus Therapeutics, Moderna Inc, Wave Life Sciences, Protagonist Therapeutics, Transgene

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Nucleic Acid Based Gene Therapy Market 2022 -Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provides nucleic acid-based gene therapy market overviews, analyses and forecasts market size, share, nucleic acid-based gene therapy market players, nucleic acid-based gene therapy market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s nucleic acid-based gene therapy market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company

Gene Therapy Global Market Report 2021

Gene Editing Global Market Report 2022

Cell And Gene Therapy Global Market Report 2021

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: